Hana Biosciences Prepares To Submit First Ondansetron Oral Spray
This article was originally published in The Pink Sheet Daily
Executive Summary
Pivotal trials confirm Zensana spray is bioequivalent to Zofran tablets for chemotherapy induced nausea and vomiting.
You may also be interested in...
Ondansetron Oral Spray Could Launch In H1 07
Hana Biosciences' ondansetron oral spray Zensana has an estimated user fee date at the end of April
Ondansetron Oral Spray Could Launch In H1 07
Hana Biosciences' ondansetron oral spray Zensana has an estimated user fee date at the end of April
FDA Rescinds Zofran ODT ANDA Approval
A prior court decision that Par's ondansetron infringes an unexpired GSK patent prompts FDA to revoke approval.